Abstract
Alcoholic liver injury resulting from excessive alcohol consumption is a significant social concern. Alcohol dehydrogenase (ADH) plays a critical role in the conversion of alcohol to acetaldehyde, leading to tissue damage. The management of alcoholic liver injury encompasses nutritional support and, in severe cases liver transplantation, but potential adverse effects exist, and effective medications are currently unavailable. Natural products with their potential benefits and historical use in traditional medicine emerge as promising alternatives. Triphala, a traditional polyherbal formula demonstrates beneficial effects in addressing diverse health concerns, with a notable impact on treating alcoholic liver damage through enhanced liver metabolism. The present study aims to identify potential active phytocompounds in Triphala targeting ADH to prevent alcoholic liver injury. Screening 119 phytocompounds from the Triphala formulation revealed 62 of them showing binding affinity to the active site of the ADH1B protein. Promising lipid-like molecule from Terminalia bellirica, (4aS, 6aR, 6aR, 6bR, 7R, 8aR, 9R, 10R, 11R, 12aR, 14bS)-7, 10, 11-trihydroxy-9-(hydroxymethyl)-2, 2, 6a, 6b, 9, 12a-hexamethyl-1, 3, 4, 5, 6, 6a, 7, 8, 8a, 10, 11, 12, 13, 14b-tetradecahydropicene-4a-carboxylic acid showed high binding efficiency to a competitive ADH inhibitor, 4-Methylpyrazole. Pharmacokinetic analysis further confirmed the drug-likeness and non-hepatotoxicity of the top-ranked compound. Molecular dynamics simulation and MM–PBSA studies revealed the stability of the docked complexes with minimal fluctuation and consistency of the hydrogen bonds throughout the simulation. Together, computational investigations suggest that (4aS, 6aR, 6aR, 6bR, 7R, 8aR, 9R, 10R, 11R, 12aR, 14bS)-7, 10, 11-trihydroxy-9-(hydroxymethyl)-2, 2, 6a, 6b, 9, 12a-hexamethyl-1, 3, 4, 5, 6, 6a, 7, 8, 8a, 10, 11, 12, 13, 14b-tetradecahydropicene-4a-carboxylic acid from the Triphala formulation holds promise as an ADH inhibitor, suggesting an alternative therapy for alcoholic liver injury.
Graphical abstract
Potential active phytocompounds in Triphala formulation targeting alcohol dehydrogenase to prevent alcoholic liver injury.
Similar content being viewed by others
Abbreviations
- WHO:
-
World Health Organization
- ADH:
-
Alcohol dehydrogenase
- ADMET:
-
Absorption, distribution, metabolism, excretion, and toxicity
- MD:
-
Molecular dynamics
- MM–PBSA:
-
Molecular mechanics–Poisson–Boltzmann surface area
- PDB:
-
Protein Data Bank
- DS:
-
Discovery Studio
- IMPPAT:
-
Indian medicinal plants, phytochemistry and therapeutics
- CGenFF:
-
CHARMM general force field
- NVT:
-
Number of particles, volume, and temperature
- NPT:
-
Number of particles, pressure, and temperature
- RMSD:
-
Root mean square deviation
- RMSF:
-
Root mean square fluctuation
References
Osna NA, Donohue TM, Kharbanda KK (2017) Alcoholic liver disease: pathogenesis and current management. Alcohol Res 38:147
World Health Organization, WHO (2022) Alcohol. https://www.who.int/news-room/fact-sheets/detail/alcohol. Accessed 10 March 2024
Yan C, Hu W, Tu J et al (2023) Pathogenic mechanisms and regulatory factors involved in alcoholic liver disease. J Transl Med. https://doi.org/10.1186/S12967-023-04166-8
Wang N, Shi H, Yao Q et al (2011) Cloning, expression and characterization of alcohol dehydrogenases in the silkworm Bombyx mori. Genet Mol Biol 34:240. https://doi.org/10.1590/S1415-47572011000200013
Singal AK, Louvet A, Shah VH, Kamath PS (2018) Grand rounds: alcoholic hepatitis. J Hepatol 69:534–543. https://doi.org/10.1016/J.JHEP.2018.05.001
Chi YC, Lee SL, Lee YP et al (2018) Modeling of human hepatic and gastrointestinal ethanol metabolism with kinetic-mechanism-based full-rate equations of the component alcohol dehydrogenase isozymes and allozymes. Chem Res Toxicol 31:556–569. https://doi.org/10.1021/ACS.CHEMRESTOX.8B00003
Edenberg HJ, McClintick JN (2018) Alcohol dehydrogenases, aldehyde dehydrogenases, and alcohol use disorders: a critical review. Alcohol Clin Exp Res 42:2281–2297. https://doi.org/10.1111/ACER.13904
Zakhari S (2006) Overview: how is alcohol metabolized by the body? Alcohol Res Health 29:245
Suganya S, Schneider L, Nandagopal B (2019) Molecular docking studies of potential inhibition of the alcohol dehydrogenase enzyme by phyllanthin, hypophyllanthin and gallic acid. Crit Rev Eukaryot Gene Expr 29:287–294. https://doi.org/10.1615/CRITREVEUKARYOTGENEEXPR.2019025602
Liu C, Ding JX, Zhou Y et al (2021) Protective effects of Lonicerae japonicae Flos against acute alcoholic liver injury in rats based on network pharmacology. Zhongguo Zhong Yao Za Zhi 46:4531–4540. https://doi.org/10.19540/J.CNKI.CJCMM.20210624.401
Baud FJ, Bismuth C, Garnier R et al (1986) 4-Methylpyrazole may be an alternative to ethanol therapy for ethylene glycol intoxication in man. J Toxicol Clin Toxicol 24:463–483. https://doi.org/10.3109/15563658608995388
Burns MJ, Graudins A, Aaron CK et al (1997) Treatment of methanol poisoning with intravenous 4-methylpyrazole. Ann Emerg Med 30:829–832. https://doi.org/10.1016/S0196-0644(97)70060-X
Brent J, McMartin K, Phillips S et al (1999) Fomepizole for the treatment of ethylene glycol poisoning. Methylpyrazole for Toxic Alcohols Study Group. N Engl J Med 340:832–838. https://doi.org/10.1056/NEJM199903183401102
Brent J, McMartin K, Phillips S et al (2001) Fomepizole for the treatment of methanol poisoning. N Engl J Med 344:424–429. https://doi.org/10.1056/NEJM200102083440605
McMartin KE (2010) Antidotes for alcohol and glycol toxicity: translating mechanisms into treatments. Clin Pharmacol Ther 88:400–404. https://doi.org/10.1038/CLPT.2010.157
Kotmire S, Desai A, Chougule N (2024) The advances in polyherbal formulation. J Pharmacogn Phytochem 13:210–221. https://doi.org/10.22271/phyto.2024.v13.i1c.14828
Ali M, Khan T, Fatima K et al (2018) Selected hepatoprotective herbal medicines: evidence from ethnomedicinal applications, animal models, and possible mechanism of actions. Phytother Res 32:199–215. https://doi.org/10.1002/PTR.5957
Wei X, Luo C, He Y et al (2021) Hepatoprotective effects of different extracts from Triphala against CCl4-induced acute liver injury in mice. Front Pharmacol. https://doi.org/10.3389/FPHAR.2021.664607
Sharma R, Jadhav M, Choudhary N et al (2022) Deciphering the impact and mechanism of Trikatu, a spices-based formulation on alcoholic liver disease employing network pharmacology analysis and in vivo validation. Front Nutr. https://doi.org/10.3389/FNUT.2022.1063118
Shah VN, Shah MB, Bhatt PA (2011) Hepatoprotective activity of punarnavashtakkwath, an Ayurvedic formulation, against CCl4-induced hepatotoxicity in rats and on the HepG2 cell line. Pharm Biol 49:408–415. https://doi.org/10.3109/13880209.2010.521162
Ray S, Taraphdar AK, Gupta M (2022) Hepatoprotective activity of Amalakyadi Gana, a polyherbal Ayurvedic formulation in paracetamol-induced hepatotoxicity in mice. J Phytopharmacol 11:255–259. https://doi.org/10.31254/phyto.2022.11405
Chauhan BL, Mohan AR, Kulkarni RD, Mitra SK (1994) Bioassay for evaluation of the hepatoprotective effect of Liv.52, a polyherbal formulation, on ethanol metabolism in chronic alcohol-exposed rats. Indian J Pharmacol 26(2):117–120
Achliya GS, Wadodkar SG, Dorle AK (2004) Evaluation of hepatoprotective effect of AmalkadiGhrita against carbon tetrachloride-induced hepatic damage in rats. J Ethnopharmacol 90:229–232. https://doi.org/10.1016/j.jep.2003.09.037
Bhattacharyya D, Pandit S, Mukherjee R et al (2003) Hepatoprotective effect of Himoliv, a polyherbal formulation in rats. Indian J Physiol Pharmacol 47:435–440
Rajesh MG, Latha MS (2004) Preliminary evaluation of the antihepatotoxic activity of Kamilari, a polyherbal formulation. J Ethnopharmacol 91:99–104. https://doi.org/10.1016/j.jep.2003.12.011
Babu PR, Bhuvaneswar C, Sandeep G et al (2017) Hepatoprotective role of Ricinus communis leaf extract against d-galactosamine induced acute hepatitis in albino rats. Biomed Pharmacother 88:658–666. https://doi.org/10.1016/J.BIOPHA.2017.01.073
Gnanadesigan M, Ravikumar S, Anand M (2017) Hepatoprotective activity of Ceriops decandra (Griff.) Ding Hou mangrove plant against CCl4 induced liver damage. J Taibah Univ Sci 11:450–457. https://doi.org/10.1016/J.JTUSCI.2016.07.004
Pereira C, Barros L, Ferreira IC (2016) Extraction, identification, fractionation and isolation of phenolic compounds in plants with hepatoprotective effects. J Sci Food Agric 96:1068–1084. https://doi.org/10.1002/JSFA.7446
Dhiman RK, Chawla YK (2005) Herbal medicines for liver diseases. Dig Dis Sci 50:1807–1812. https://doi.org/10.1007/S10620-005-2942-9
Peterson CT, Denniston K, Chopra D (2017) Therapeutic uses of Triphala in Ayurvedic medicine. J Altern Complement Med 23:607–614. https://doi.org/10.1089/ACM.2017.0083
Mukherjee PK, Rai S, Bhattacharyya S, Debnath K (2006) Clinical study of ‘Triphala’—a well known phytomedicine from India. Iran J Pharmacol Ther 5(1):51–54
Sabu MC, Kuttan R (2002) Anti-diabetic activity of medicinal plants and its relationship with their antioxidant property. J Ethnopharmacol 81:155–160. https://doi.org/10.1016/S0378-8741(02)00034-X
Biradar YS, Jagatap S, Khandelwal KR, Singhania SS (2008) Exploring of antimicrobial activity of TriphalaMashi—an Ayurvedic formulation. Evid Based Complement Altern Med 5:107–113. https://doi.org/10.1093/ECAM/NEM002
Rasool M, Sabina EP (2007) Antiinflammatory effect of the Indian Ayurvedic herbal formulation Triphala on adjuvant-induced arthritis in mice. Phytother Res 21:889–894. https://doi.org/10.1002/PTR.2183
Gupta SK, Kalaiselvan V, Srivastava S et al (2010) Evaluation of anticataract potential of Triphala in selenite-induced cataract: in vitro and in vivo studies. J Ayurveda Integr Med 1:280. https://doi.org/10.4103/0975-9476.74425
Baliga MS (2010) Triphala, Ayurvedic formulation for treating and preventing cancer: a review. J Altern Complement Med 16:1301–1308. https://doi.org/10.1089/ACM.2009.0633
Abhinand CS, Athira PA, Soumya SJ, Sudhakaran PR (2020) Multiple targets directed multiple ligands: an in silico and in vitro approach to evaluating the effect of Triphala on angiogenesis. Biomolecules. https://doi.org/10.3390/BIOM10020177
Srikumar R, Jeya Parthasarathy N, Sheela Devi R (2005) Immunomodulatory activity of Triphala on neutrophil functions. Biol Pharm Bull 28:1398–1403. https://doi.org/10.1248/BPB.28.1398
Pfundstein B, El Desouky SK, Hull WE et al (2010) Polyphenolic compounds in the fruits of Egyptian medicinal plants (Terminalia bellirica, Terminalia chebula and Terminalia horrida): characterization, quantitation and determination of antioxidant capacities. Phytochemistry 71:1132–1148. https://doi.org/10.1016/J.PHYTOCHEM.2010.03.018
Kumar N, Khurana SMP (2018) Phytochemistry and medicinal potential of the Terminalia bellirica Roxb. (Bahera). Indian J Nat Prod Resour 9(2):97–107
Ur-Rehman H, Yasin KA, Choudhary MA et al (2007) Studies on the chemical constituents of Phyllanthus emblica. Nat Prod Res 21:775–781. https://doi.org/10.1080/14786410601124664
Pawar V, Lahorkar P, Anantha Narayana DB (2009) Development of a RP-HPLC method for analysis of TriphalaCurna and its applicability to test variations in TriphalaCurna preparations. Indian J Pharm Sci 71:382–386. https://doi.org/10.4103/0250-474X.57286
Baliga MS, Meera S, Mathai B et al (2012) Scientific validation of the ethnomedicinal properties of the Ayurvedic drug Triphala: a review. Chin J Integr Med 18:946–954. https://doi.org/10.1007/S11655-012-1299-X
Sandhya T, Lathika KM, Pandey BN, Mishra KP (2006) Potential of traditional Ayurvedic formulation, Triphala, as a novel anticancer drug. Cancer Lett 231:206–214. https://doi.org/10.1016/J.CANLET.2005.01.035
Hurley TD, Bosron WF, Stone CL, Amzel LM (1994) Structures of three human beta alcohol dehydrogenase variants. Correlations with their functional differences. J Mol Biol 239:415–429. https://doi.org/10.1006/JMBI.1994.1382
Berman HM, Westbrook J, Feng Z et al (2000) The Protein Data Bank. Nucleic Acids Res 28:235–242. https://doi.org/10.1093/NAR/28.1.235
Mohanraj K, Karthikeyan BS, Vivek-Ananth RP et al (2018) IMPPAT: a curated database of Indian Medicinal Plants, Phytochemistry and Therapeutics. Sci Rep. https://doi.org/10.1038/S41598-018-22631-Z
Duke JA (1992) Database of biologically active phytochemicals and their activity. CRC Press, Boca Raton
Kim S, Chen J, Cheng T et al (2019) PubChem 2019 update: improved access to chemical data. Nucleic Acids Res 47:D1102–D1109. https://doi.org/10.1093/NAR/GKY1033
Diller DJ, Merz KM (2001) High throughput docking for library design and library prioritization. Proteins 43:113–124. https://doi.org/10.1002/1097-0134(20010501)43:2%3c113::aid-prot1023%3e3.0.co;2-t
Rao SN, Head MS, Kulkarni A, LaLonde JM (2007) Validation studies of the site-directed docking program LibDock. J Chem Inf Model 47:2159–2171. https://doi.org/10.1021/CI6004299
Liao J, Wang Q, Wu F, Huang Z (2022) In silico methods for identification of potential active sites of therapeutic targets. Molecules 27:7103. https://doi.org/10.3390/molecules27207103
Xiong G, Wu Z, Yi J et al (2021) ADMETlab 2.0: an integrated online platform for accurate and comprehensive predictions of ADMET properties. Nucleic Acids Res 49:W5–W14. https://doi.org/10.1093/NAR/GKAB255
Van Der Spoel D, Lindahl E, Hess B et al (2005) GROMACS: fast, flexible, and free. J Comput Chem 26:1701–1718. https://doi.org/10.1002/JCC.20291
Pronk S, Páll S, Schulz R et al (2013) GROMACS 4.5: a high-throughput and highly parallel open source molecular simulation toolkit. Bioinformatics 29:845–854. https://doi.org/10.1093/BIOINFORMATICS/BTT055
Brooks BR, Bruccoleri RE, Olafson BD et al (1983) CHARMM: a program for macromolecular energy, minimization, and dynamics calculations. J Comput Chem 4:187–217. https://doi.org/10.1002/JCC.540040211
Huang J, Rauscher S, Nawrocki G et al (2017) CHARMM36m: an improved force field for folded and intrinsically disordered proteins. Nat Methods 14:71–73. https://doi.org/10.1038/NMETH.4067
Vanommeslaeghe K, Hatcher E, Acharya C et al (2010) CHARMM general force field: a force field for drug-like molecules compatible with the CHARMM all-atom additive biological force fields. J Comput Chem 31:671–690. https://doi.org/10.1002/JCC.21367
Jorgensen WL, Chandrasekhar J, Madura JD et al (1983) Comparison of simple potential functions for simulating liquid water. J Chem Phys 79:926–935. https://doi.org/10.1063/1.445869
Sun D, Lakkaraju SK, Jo S, Mackerell AD (2018) Determination of ionic hydration free energies with grand canonical Monte Carlo/molecular dynamics simulations in explicit water. J Chem Theory Comput 14:5290–5302. https://doi.org/10.1021/ACS.JCTC.8B00604
Nosé S (1984) A molecular dynamics method for simulations in the canonical ensemble. Mol Phys 52:255–268. https://doi.org/10.1080/00268978400101201
Nosé S, Klein ML (1983) Constant pressure molecular dynamics for molecular systems. Mol Phys 50:1055–1076. https://doi.org/10.1080/00268978300102851
Turner PJ (2005) XMGRACE, version 5.1.19. Center for Coastal and Land-Margin Research, Oregon Graduate Institute of Science and Technology, Beaverton
Valdés-Tresanco MS, Valdés-Tresanco ME, Valiente PA, Moreno E (2021) gmx_MMPBSA: a new tool to perform end-state free energy calculations with GROMACS. J Chem Theory Comput 17:6281–6291. https://doi.org/10.1021/ACS.JCTC.1C00645
Patil R, Das S, Stanley A et al (2010) Optimized hydrophobic interactions and hydrogen bonding at the target–ligand interface leads the pathways of drug-designing. PLoS ONE 5:e12029. https://doi.org/10.1371/journal.pone.0012029
Alamri ZZ (2018) The role of liver in metabolism: an updated review with physiological emphasis. Int J Basic Clin Pharmacol 7:2271. https://doi.org/10.18203/2319-2003.IJBCP20184211
Jaeschke H (2011) Reactive oxygen and mechanisms of inflammatory liver injury: present concepts. J Gastroenterol Hepatol 26:173–179. https://doi.org/10.1111/J.1440-1746.2010.06592.X
Amin A, Hamza AA (2005) Oxidative stress mediates drug-induced hepatotoxicity in rats: a possible role of DNA fragmentation. Toxicology 208:367–375. https://doi.org/10.1016/J.TOX.2004.11.039
Blomstrand R, Ellin Å, Löf A, Östling-Wintzell H (1980) Biological effects and metabolic interactions after chronic and acute administration of 4-methylpyrazole and ethanol to rats. Arch Biochem Biophys 199:591–605. https://doi.org/10.1016/0003-9861(80)90317-3
Abbas Z, Manoharan AL, Jagadeesan G et al (2021) Evaluation of an edible polyherbal formulation against urinary tract infection pathogens, its antioxidant and anti-inflammatory potential. Biocatal Agric Biotechnol 35:102104. https://doi.org/10.1016/j.bcab.2021.102104
World Health Organization, WHO (2023) Traditional medicine. https://www.who.int/news-room/questions-and-answers/item/traditional-medicine. Accessed 10 March 2024
Chattopadhyay RR, Bhattacharyya SK (2007) PHCOG REV.: plant review Terminalia chebula: an update. Pharmaacogn Rev 1(1)
Parveen R, Shamsi TN, Singh G et al (2018) Phytochemical analysis and in vitro biochemical characterization of aqueous and methanolic extract of Triphala, a conventional herbal remedy. Biotechnol Rep (Amst) 17:126–136. https://doi.org/10.1016/J.BTRE.2018.02.003
Chaphalkar R, Apte KG, Talekar Y et al (2017) Antioxidants of Phyllanthus emblica L. bark extract provide hepatoprotection against ethanol-induced hepatic damage: a comparison with silymarin. Oxid Med Cell Longev. https://doi.org/10.1155/2017/3876040
Choi MK, Kim HG, Han JM et al (2015) Hepatoprotective effect of Terminalia chebula against t-BHP-induced acute liver injury in C57/BL6 mice. Evid Based Complement Altern Med. https://doi.org/10.1155/2015/517350
Jadon A, Bhadauria M, Shukla S (2007) Protective effect of Terminalia bellirica Roxb. and gallic acid against carbon tetrachloride induced damage in albino rats. J Ethnopharmacol 109:214–218. https://doi.org/10.1016/J.JEP.2006.07.033
Kuriakose J, Lal Raisa H, Vysakh A et al (2017) Terminalia bellirica (Gaertn.) Roxb. fruit mitigates CCl4 induced oxidative stress and hepatotoxicity in rats. Biomed Pharmacother 93:327–333. https://doi.org/10.1016/J.BIOPHA.2017.06.080
Jayesh K, Helen LR, Vysakh A et al (2019) Protective role of Terminalia bellirica (Gaertn.) Roxb fruits against CCl4 induced oxidative stress and liver injury in rodent model. Indian J Clin Biochem 34:155–163. https://doi.org/10.1007/S12291-017-0732-8
Lee CY, Peng WH, Cheng HY et al (2006) Hepatoprotective effect of Phyllanthus in Taiwan on acute liver damage induced by carbon tetrachloride. Am J Chin Med (Gard City NY) 34:471–482. https://doi.org/10.1142/S0192415X06004004
Ahmadi-Naji R, Heidarian E, Ghatreh-Samani K (2017) Evaluation of the effects of the hydroalcoholic extract of Terminalia chebula fruits on diazinon-induced liver toxicity and oxidative stress in rats. Avicenna J Phytomed 7:454
Rashed K, Potočnjak I, Giacometti J et al (2014) Terminalia bellirica aerial parts ethyl acetate extract exhibits antioxidant, anti-inflammatory and antifibrotic activity in carbon tetrachloride-intoxicated mice. J Funct Foods 8:319–330. https://doi.org/10.1016/j.jff.2014.03.033
Gupta A, Pandey AK (2020) Aceclofenac-induced hepatotoxicity: an ameliorative effect of Terminalia bellirica fruit and ellagic acid. World J Hepatol 12:949–964. https://doi.org/10.4254/WJH.V12.I11.949
Singh DP, Mani D (2015) Protective effect of TriphalaRasayana against paracetamol-induced hepato-renal toxicity in mice. J Ayurveda Integr Med 6:181–186. https://doi.org/10.4103/0975-9476.146553
Phetkate P, Kummalue T, Rinthong P-O et al (2020) Study of the safety of oral Triphala aqueous extract on healthy volunteers. J Integr Med 18:35–40. https://doi.org/10.1016/J.JOIM.2019.10.002
Naveed M, Tehreem S, Mubeen S et al (2016) In silico analysis of non-synonymous-SNPs of STEAP2: to provoke the progression of prostate cancer. Open Life Sci 11:402–416. https://doi.org/10.1515/biol-2016-0054
Saleem A, Afzal M, Naveed M et al (2022) HPLC, FTIR and GC–MS analyses of Thymus vulgaris phytochemicals executing in vitro and in vivo biological activities and effects on COX-1, COX-2 and gastric cancer genes computationally. Molecules 27:8512. https://doi.org/10.3390/molecules27238512
Acknowledgements
We thank the Yenepoya (Deemed to be University) for providing the necessary facility to the Center for Systems Biology and Molecular Medicine (CSBMM) and the Centre for Integrative Omics Data Science (CIODS), to carry out this study.
Funding
This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Author information
Authors and Affiliations
Contributions
CSA developed the original hypothesis and the computational workflow. CSA and BB conducted molecular docking, ADMET, dynamics studies, and binding-free energy calculations. BB drafted the initial manuscript. CSA, RR, and TSKP critically evaluated the manuscript to ensure the scientific validity of the study. All authors read, edited, and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Banjan, B., Raju, R., Keshava Prasad, T.S. et al. Computational identification of potential bioactive compounds from Triphala against alcoholic liver injury by targeting alcohol dehydrogenase. Mol Divers (2024). https://doi.org/10.1007/s11030-024-10879-9
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s11030-024-10879-9